#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal atresia Raynaud's phenomenon Brain injury Neuromyelitis optica spectrum disorder Dilated cardiomyopathy Henoch-Schonlein purpura nephritis Pulmonary sarcoidosis Pulmonary arterial hypertension Sjogren's syndrome Myotonia Metastases to peritoneum Arrhythmogenic right ventricular dysplasia Epidermolysis bullosa Chronic graft versus host disease Mitochondrial DNA depletion More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II – Basic Information Adrenogenital syndrome – Trials in Disease Mantle cell lymphoma stage II – Trials in Disease Primary hyperoxaluria – Diagnostics Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Treatment Systemic mastocytosis – Life with Disease Cystic fibrosis – Diagnostics Gaucher’s disease type III – Basic Information Myelodysplastic syndrome – Trials in Disease Niemann-Pick disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ABBV-CLS-628 Gskvx000000014593 Epcoritamab ZOLPIDEM TARTRATE Fasudil Hydrochloride L-ALANINE Soya Oil, Purified Quinidine Sulfate GVV858 Meropenem Avibactam Sodium Stro-002 Livmoniplimab Ck-0045 Sotagliflozin Hypromellose Meldonium Methotrexate Sodium Cisplatin Dinoprostone More therapies…

    Learn about Your Condition

    Obstructive pancreatitis Porphyria non-acute Hairy cell leukaemia Adenovirus infection Pancreatic carcinoma Oesophageal achalasia Precocious puberty Acne Myotonic dystrophy Myocardial ischaemia Conjunctivitis Fabry's disease Plasmablastic lymphoma Craniotomy Anal cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut de Cancérologie Hématologie Universitaire…

Institut de Cancérologie Hématologie Universitaire de Saint Etienne (iCHUSE)

Avenue Albert Raimond, Saint Priest En Jarez, 42270, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on EXL01 to Prevent Recurrence of C. difficile Infection in High-Risk Patients

    Recruiting

    1 1 1
    Investigated Diseases:
    • Clostridium difficile infection
    Investigated Drugs:
    • Exl01
    • Vancomycin
    France

  • Study Comparing Vedolizumab and Adalimumab for Crohn’s Disease Patients Who No Longer Respond to Adalimumab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Adalimumab
    • Vedolizumab
    France

  • Study Comparing CPX-351 and Chemotherapy for Patients with New Intermediate or High-Risk Acute Myeloid Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Idarubicin
    • Cytarabine
    • Daunorubicin
    France

  • Study on the Effectiveness and Safety of Rituximab for Patients with Progressive Interstitial Lung Disease with Inflammation

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Sodium Chloride Ph. Eur.
    • Rituximab
    France

  • Study on Aspirin for Preventing Preeclampsia in First-Time Pregnant Women Using Assisted Reproductive Technology

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pre-eclampsia
    Investigated Drugs:
    • Acetylsalicylic Acid
    France

  • Study on Blood Pressure Management with Amiloride Hydrochloride, Indapamide, and Furosemide for Patients with Uncontrolled Hypertension and Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypertension
    • Chronic kidney disease
    Investigated Drugs:
    • Amiloride Hydrochloride
    • Furosemide
    • Hydrochlorothiazide
    France

  • Study on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Asparaginase
    • Blinatumomab
    • Cyclophosphamide Monohydrate
    Austria Belgium Czechia Denmark Finland France +13

  • Study on Vinblastine for Children and Adolescents with Standard Risk ALK-Positive Anaplastic Large Cell Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anaplastic large cell lymphoma T- and null-cell types
    Investigated Drugs:
    • Vinblastine Sulfate
    Austria Belgium Denmark Finland France Germany +2

  • Study on MaaT033 to Prevent Complications in Patients with Blood Cancer Undergoing Stem Cell Transplantation

    Recruiting

    2 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Belgium France Germany The Netherlands Spain

  • Study on the Benefits of Autologous Stem Cell Transplantation for Patients with Peripheral T-cell Lymphoma Using Etoposide and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Brentuximab Vedotin
    • Methylprednisolone Hemisuccinate
    • Cyclophosphamide Monohydrate
    Belgium France
Previous Page
1 … 16 17 18 19 20 … 46
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!